Clinical Trial

Lemborexant Treatment of Insomnia Linked to Epilepsy

Study acronym: L'ÉTOILE
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2025 (before its estimated April 18, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-14; most recent amendment 2025-02-10.
Status change: Not Yet Recruiting → Recruiting 2024-05-06
Trial Details
NCT Number NCT06262594
Lead Sponsor University of Manitoba
Collaborators: Duke University
Conditions Epilepsy, Sleep
Enrollment 26 participants
Start Date 2024-10-29
Primary Completion 2026-04-18 (estimated)
Study Completion 2027-04-18 (estimated)
Updated on ClinicalTrials.gov 2025-02-13